Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine vs Supportive Care in Advanced MDS
NCT00043381Phase 3Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Apr 2001
- Primary completion
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Astex Pharmaceuticals. Started Apr 2001; status: completed.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00043381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043381.